Talking your way to better blood sugar: new study tests storytelling as diabetes tool
NCT ID NCT07307430
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a structured storytelling education program can help adults with type 2 diabetes improve their blood sugar control. About 226 participants will either receive standard care or standard care plus two face-to-face storytelling sessions and four brief phone calls over three months. The main goal is to see if the program lowers HbA1c levels, a key measure of blood sugar control.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Structured narrative education program (behavioral intervention)
What this could lead to
If it works, this could offer a simple, low-cost way to help people with type 2 diabetes better manage their blood sugar through improved self-care.
What could go wrong
This is a small, early-stage trial with only 226 participants. The program may not produce meaningful improvements in blood sugar, and results may not apply to all diabetes patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS (T2DM) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ozerli Family Health Center No. 4
Antakya, Hatay, 31600, Turkey (Türkiye)
Contact Phone: •••-•••-•••• Email: •••••@•••••